Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
Eur Rev Med Pharmacol Sci ; 23(24): 10976-10981, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31858567

RESUMO

OBJECTIVE: To explore the effects of long non-coding ribonucleic acid (lncRNA) Gm4419 on rats with hypertensive cerebral atherosclerosis through the nuclear factor-kappa B (NF-κB) pathway. MATERIALS AND METHODS: Healthy male rats were selected and randomly divided into control group, model group (hypertensive cerebral atherosclerosis model), and lncRNA group (hypertensive cerebral atherosclerosis model + lncRNA injection). Neurological deficit scoring criteria, flow cytometry, Western blotting, and staining method were adopted to measure the differences in the neurological function score, NF-κB activity, and chemerin level of rats in the three groups. RESULTS: The neurological scores revealed that the neurological function of rats was not damaged in control group, while it was severely damaged in model group. However, the neurological function of rats was more severely damaged in lncRNA group than that in control group and model group, while the neurological function deficits were slighter in model group. In terms of NF-κB expression activity in mononuclear cells, the serum activity of NF-κB in control group appeared the lowest among the three groups and was significantly higher in lncRNA group than in model group. The serum chemerin level was evidently increased in model group compared with control group, while it was significantly decreased in lncRNA group compared with model group and control group. Moreover, the levels of NF-κB and chemerin were most evidently influenced in lncRNA group. CONCLUSIONS: Activating the NF-κB signal, lncRNA Gm4419 promotes the expression of chemerin signal, accelerates the apoptosis of nerve cells, and motivates the deterioration of hypertensive cerebral arteriosclerosis.


Assuntos
Hipertensão/metabolismo , Arteriosclerose Intracraniana/metabolismo , NF-kappa B/metabolismo , RNA Longo não Codificante/metabolismo , Animais , Modelos Animais de Doenças , Hipertensão/patologia , Arteriosclerose Intracraniana/patologia , Masculino , NF-kappa B/análise , NF-kappa B/genética , RNA Longo não Codificante/genética , Ratos
3.
Poult Sci ; 89(10): 2259-64, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20852117

RESUMO

Influenza is a topic of wide public concern, particularly because of the recent emergence of avian flu. The myxovirus resistance (Mx) protein has been shown to have an inhibitory effect on influenza virus and is therefore of great interest. This study examines the Mx protein in 8 local Chinese chicken breeds and 2 exotic chicken breeds. Amino acid 631, found in the Mx GTPase effector domain, was examined in 534 individuals by comparing PCR results, and individuals were separated into the A/A genotype or the G/G genotype, depending on whether amino acid 631 is an Asn or Ser. In the native breed, the frequency of G/G homozygotes is 0.780 (294/377). The Mx expression levels in tissues and chicken embryo fibroblast cells with different genotypes were also studied. The A/A individuals from Beijing-You and White Leghorn breeds had higher Mx expression levels than G/G individuals. The liver, heart, and spleen had higher expression levels than muscle or kidney. The A/A chicken embryo fibroblast cells had higher antiviral activity against vesicular stomatitis virus and Newcastle disease. We provide the first report examining the expression level and antiviral activity of different Mx alleles of nucleotide 2216(S631N) genotypes. This study lays a good foundation for correlative studies examining genotype and antiviral function.


Assuntos
Substituição de Aminoácidos , Galinhas/genética , Proteínas de Ligação ao GTP/genética , Regulação da Expressão Gênica/imunologia , Orthomyxoviridae/fisiologia , Animais , Células Cultivadas , Fibroblastos/efeitos dos fármacos , Proteínas de Ligação ao GTP/metabolismo , Proteínas de Ligação ao GTP/farmacologia , Predisposição Genética para Doença , Genótipo , Proteínas de Resistência a Myxovirus , Infecções por Orthomyxoviridae/genética , Infecções por Orthomyxoviridae/veterinária , Doenças das Aves Domésticas/genética , Doenças das Aves Domésticas/virologia , RNA Mensageiro , RNA Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA